MIRIAM CARNEMOLLA: Open Payments
NPI 1235465162 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 11 payments from 9 companies in 2025. Trend: 2023 $1,688 · 2024 $1,402 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $222 |
| Amgen Inc. | 2 | $146 |
| Grifols USA, LLC | 1 | $137 |
| Actelion Pharmaceuticals US, Inc. | 1 | $137 |
| JAZZ PHARMACEUTICALS INC. | 1 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Exact Sciences Corporation | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: Prolastin-C Liquid, UPTRAVI, XYWAV, TEZSPIRE, BREZTRI, The Cologuard Plus Collection Kit, REPATHA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
